Acute Kidney Injury Models

This case study compiles three validated rodent AKI models, ischemia-reperfusion, cisplatin‑induced, and iohexol‑induced nephropathy, to support renoprotective candidate evaluation. Each model includes longitudinal renal function biomarkers (serum CREA/BUN), histopathological scoring, inflammatory cell profiling, and urinary albumin readouts, providing a comprehensive translational platform for nephrology drug discovery.

Download

Acute Kidney Injury Models in C57BL6 mice

What Makes This Case Study Essential for Your Renal Research?

Diverse, Clinically Relevant AKI Models

Covers ischemia‑reperfusion injury (IRI), cisplatin chemotherapy‑related nephrotoxicity, and contrast‑induced (iohexol) AKI, mirroring common clinical scenarios to address different mechanistic pathways.

Multimodal Efficacy Readouts

Goes beyond standard CREA and BUN measurements to include H&E/PAS histomorphometry, MPO immunohistochemistry for neutrophil infiltration, urinary albumin excretion, and body weight trajectory, enabling a holistic assessment of compound renoprotection.

Direct Comparative Data Across Dosing Regimens

Highlights dose‑dependent responses in cisplatin‑induced nephropathy, offering practical insights into study design and toxicity management for translational projects.

Actionable Pathological Scoring Systems

Provides quantitative renal injury scores, infarction area evaluation, and tubular damage grading, supporting robust statistical comparisons and reproducible decision‑making.

Download the full case study to access complete experimental schedules, raw data figures, and detailed assay protocols—accelerate your AKI drug development with Ace Therapeutics' validated preclinical platform.

Fill In This Form to Get Our Case Study.